Anaerobutyricum hallii DSM 3353 is an anaerobe, mesophilic prokaryote that was isolated from human faeces.
anaerobe mesophilic genome sequence 16S sequence
SI-ID 39157
| @ref 20215 |
Last LPSN update
2025-12-16 09:48:04 |
| Domain Bacillati |
| Phylum Bacillota |
| Class Clostridia |
| Order Eubacteriales |
| Family Lachnospiraceae |
| Genus Anaerobutyricum |
| Species Anaerobutyricum hallii |
| Full scientific name Anaerobutyricum hallii (Holdeman and Moore 1974) Shetty et al. 2018 |
| Synonyms (1) |
| BacDive ID | Other strains from Anaerobutyricum hallii (1) | Type strain |
|---|---|---|
| 163991 | A. hallii JCM 31263 |
| @ref | Name | Growth | Medium link | Composition | |
|---|---|---|---|---|---|
| 1360 | PYG MEDIUM (MODIFIED) (DSMZ Medium 104) | Medium recipe at MediaDive  | Name: PYG MEDIUM (modified) (DSMZ Medium 104) Composition: Yeast extract 10.0 g/l Peptone 5.0 g/l Trypticase peptone 5.0 g/l Beef extract 5.0 g/l Glucose 5.0 g/l L-Cysteine HCl x H2O 0.5 g/l NaHCO3 0.4 g/l NaCl 0.08 g/l K2HPO4 0.04 g/l KH2PO4 0.04 g/l MgSO4 x 7 H2O 0.02 g/l CaCl2 x 2 H2O 0.01 g/l Hemin 0.005 g/l Ethanol 0.0038 g/l Resazurin 0.001 g/l Tween 80 Vitamin K1 NaOH Distilled water | ||
| 1360 | CHOPPED MEAT MEDIUM WITH CARBOHYDRATES (DSMZ Medium 110) | Medium recipe at MediaDive | Name: CHOPPED MEAT MEDIUM WITH CARBOHYDRATES (DSMZ Medium 110) Composition: Ground beef 500.0 g/l Casitone 30.0 g/l Agar 15.0 g/l K2HPO4 5.0 g/l Yeast extract 5.0 g/l D-Glucose 4.0 g/l Starch 1.0 g/l Maltose 1.0 g/l Cellobiose 1.0 g/l L-Cysteine HCl 0.5 g/l Ethanol 0.19 g/l Vitamin K3 0.05 g/l Hemin 0.005 g/l Sodium resazurin 0.0005 g/l Vitamin K1 NaOH Distilled water |
| @ref | Growth | Type | Temperature (°C) | Range | |
|---|---|---|---|---|---|
| 1360 | positive | growth | 37 | mesophilic |
| @ref | Chebi-ID | Metabolite | Utilization activity | Kind of utilization tested | |
|---|---|---|---|---|---|
| 68380 | 29016 ChEBI | arginine | - | hydrolysis | from API rID32A |
| 68380 | 16024 ChEBI | D-mannose | - | fermentation | from API rID32A |
| 68380 | 29985 ChEBI | L-glutamate | - | degradation | from API rID32A |
| 68380 | 17632 ChEBI | nitrate | - | reduction | from API rID32A |
| 68380 | 16634 ChEBI | raffinose | - | fermentation | from API rID32A |
| 68380 | 27897 ChEBI | tryptophan | - | energy source | from API rID32A |
| 68380 | 16199 ChEBI | urea | - | hydrolysis | from API rID32A |
| @ref | Chebi-ID | Metabolite | Production | |
|---|---|---|---|---|
| 68380 | 35581 ChEBI | indole | from API rID32A |
| @ref | Chebi-ID | Metabolite | Indole test | |
|---|---|---|---|---|
| 68380 | 35581 ChEBI | indole | - | from API rID32A |
| @ref | Value | Activity | Ec | |
|---|---|---|---|---|
| 68380 | alanine arylamidase | - | 3.4.11.2 | from API rID32A |
| 68380 | alkaline phosphatase | - | 3.1.3.1 | from API rID32A |
| 68380 | alpha-arabinosidase | - | 3.2.1.55 | from API rID32A |
| 68380 | alpha-fucosidase | - | 3.2.1.51 | from API rID32A |
| 68380 | alpha-galactosidase | - | 3.2.1.22 | from API rID32A |
| 68380 | alpha-glucosidase | - | 3.2.1.20 | from API rID32A |
| 68380 | arginine dihydrolase | - | 3.5.3.6 | from API rID32A |
| 68380 | beta-Galactosidase 6-phosphate | - | from API rID32A | |
| 68380 | beta-glucosidase | - | 3.2.1.21 | from API rID32A |
| 68380 | beta-glucuronidase | - | 3.2.1.31 | from API rID32A |
| 68380 | glutamate decarboxylase | - | 4.1.1.15 | from API rID32A |
| 68380 | glutamyl-glutamate arylamidase | - | from API rID32A | |
| 68380 | glycin arylamidase | - | from API rID32A | |
| 68380 | histidine arylamidase | - | from API rID32A | |
| 68380 | L-arginine arylamidase | - | from API rID32A | |
| 68380 | leucine arylamidase | - | 3.4.11.1 | from API rID32A |
| 68380 | leucyl glycin arylamidase | - | 3.4.11.1 | from API rID32A |
| 68380 | N-acetyl-beta-glucosaminidase | - | 3.2.1.52 | from API rID32A |
| 68380 | phenylalanine arylamidase | - | from API rID32A | |
| 68380 | proline-arylamidase | - | 3.4.11.5 | from API rID32A |
| 68380 | pyrrolidonyl arylamidase | - | 3.4.19.3 | from API rID32A |
| 68380 | serine arylamidase | - | from API rID32A | |
| 68380 | tryptophan deaminase | - | 4.1.99.1 | from API rID32A |
| 68380 | tyrosine arylamidase | - | from API rID32A | |
| 68380 | urease | - | 3.5.1.5 | from API rID32A |
| @ref | URE | ADH (Arg) | alpha GAL | beta GAL | beta-Galactosidase 6-phosphatebeta GP | alpha GLU | beta GLU | alpha ARA | beta GUR | beta-N-Acetyl-beta-glucosaminidasebeta NAG | MNE | RAF | GDC | alpha FUC | Reduction of nitrateNIT | IND | PAL | L-arginine arylamidaseArgA | ProA | LGA | Phenylalanine arylamidasePheA | Leucine arylamidaseLeuA | PyrA | Tyrosine arylamidaseTyrA | Alanine arylamidaseAlaA | Glycin arylamidaseGlyA | Histidine arylamidaseHisA | Glutamyl-glutamate arylamidaseGGA | Serine arylamidaseSerA | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1360 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | |
| 1360 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | |
| 1360 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | |
| 1360 | - | - | not determinedn.d. | + | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Title | Authors | Journal | DOI | Year | |
|---|---|---|---|---|---|
| In vitro investigations on the impact of fermented dairy constituents on fecal microbiota composition and fermentation activity. | Li Q, Marietou A, Andersen FF, Hosek J, Scavenius C, Zhang J, Schwab C. | Microbiol Spectr | 10.1128/spectrum.02193-24 | 2025 | |
| Gorse (Ulex europeaus) wastes with 5,6-dimethyl benzimidazole supplementation can support growth of vitamin B12 producing commensal gut microbes. | Iyer A, Soto Martin EC, Cameron GA, Louis P, Duncan SH, Bestwick CS, Russell WR. | PLoS One | 10.1371/journal.pone.0290052 | 2024 | |
| Ecology- and genome-based identification of the Bifidobacterium adolescentis prototype of the healthy human gut microbiota. | Argentini C, Lugli GA, Tarracchini C, Fontana F, Mancabelli L, Viappiani A, Anzalone R, Angelini L, Alessandri G, Bianchi MG, Taurino G, Bussolati O, Milani C, van Sinderen D, Turroni F, Ventura M. | Appl Environ Microbiol | 10.1128/aem.02014-23 | 2024 | |
| Roles of human colonic bacteria in pectin utilization and associated cross-feeding networks revealed using synthetic co-cultures. | Solvang M, Farquharson FM, Horgan G, Pisano S, Holck J, Zeuner B, Russell WR, Louis P. | Microbiology (Reading) | 10.1099/mic.0.001559 | 2025 | |
| Mucin-driven ecological interactions in an in vitro synthetic community of human gut microbes. | Berkhout MD, Ioannou A, de Ram C, Boeren S, Plugge CM, Belzer C. | Glycobiology | 10.1093/glycob/cwae085 | 2024 | |
| Butyrate producers, "The Sentinel of Gut": Their intestinal significance with and beyond butyrate, and prospective use as microbial therapeutics. | Singh V, Lee G, Son H, Koh H, Kim ES, Unno T, Shin JH. | Front Microbiol | 10.3389/fmicb.2022.1103836 | 2022 | |
| A Platform for Co-Culture of Primary Human Colonic Epithelium With Anaerobic Probiotic Bacteria. | Kim R, Wang Y, Sims CE, Allbritton NL. | Front Bioeng Biotechnol | 10.3389/fbioe.2022.890396 | 2022 | |
| Determination of Butyrate Synthesis Capacity in Gut Microbiota: Quantification of but Gene Abundance by qPCR in Fecal Samples. | Daskova N, Heczkova M, Modos I, Videnska P, Splichalova P, Pelantova H, Kuzma M, Gojda J, Cahova M. | Biomolecules | 10.3390/biom11091303 | 2021 | |
| Prevalent Human Gut Bacteria Hydrolyse and Metabolise Important Food-Derived Mycotoxins and Masked Mycotoxins. | Daud N, Currie V, Duncan G, Farquharson F, Yoshinari T, Louis P, Gratz S. | Toxins (Basel) | 10.3390/toxins12100654 | 2020 | |
| How microbial glycosyl hydrolase activity in the gut mucosa initiates microbial cross-feeding. | Berkhout MD, Plugge CM, Belzer C. | Glycobiology | 10.1093/glycob/cwab105 | 2022 | |
| Insights Into the Resistome of Bovine Clinical Mastitis Microbiome, a Key Factor in Disease Complication. | Hoque MN, Istiaq A, Clement RA, Gibson KM, Saha O, Islam OK, Abir RA, Sultana M, Siddiki AZ, Crandall KA, Hossain MA. | Front Microbiol | 10.3389/fmicb.2020.00860 | 2020 | |
| Protection against fibrosis by a bacterial consortium in metabolic dysfunction-associated steatohepatitis and the role of amino acid metabolism. | Kwan SY, Gonzales KA, Jamal MA, Stevenson HL, Tan L, Lorenzi PL, Futreal PA, Hawk ET, McCormick JB, Fisher-Hoch SP, Jenq RR, Beretta L. | Gut Microbes | 10.1080/19490976.2024.2399260 | 2024 | |
| Genomic mechanisms underlying the adaptation of Anaerobutyricum species to the human host. | Gu C, Wang D, Han K, Li J, Chen L, Zhuang Q, Yao T, Wei H, Yue J, Hua M, Chen C. | Infect Genet Evol | 10.1016/j.meegid.2025.105844 | 2025 | |
| The impact of Bifidobacterium longum CCFM1112 on chronic constipation: a randomised, double-blind, placebo-controlled study. | Liu W, Wang J, Xue Y, Li J, Huang Y, Zhu S, Wang L, Wang G, Chen W, Zhao J. | Benef Microbes | 10.1163/18762891-bja00085 | 2025 | |
| Reproducing in vitro artificial gut microbiota using glycerol stocks of fecal cultures combined with different prebiotic additives. | Sasaki K, Takeshima Y, Fujino A. | J Biosci Bioeng | 10.1016/j.jbiosc.2025.06.002 | 2025 | |
| Galacto-Oligosaccharides Exert Bifidogenic Effects at Capsule-Compatible Ultra-Low Doses. | Harthoorn LF, Heyse J, Baudot A, van Hengel IAJ, Van den Abbeele P. | Metabolites | 10.3390/metabo15080530 | 2025 | |
| Megasphaera contributes to lactate-driven valerate production in the human gut. | Huertas-Diaz L, Gezer ME, Marietou A, Hosek J, Thams L, Dalgaard LB, Hansen M, Schwab C. | Microbiome | 10.1186/s40168-025-02207-6 | 2025 | |
| Effects of Italian Mediterranean Organic Diet on the Gut Microbiota: A Pilot Comparative Study with Conventional Products and Free Diet. | Di Renzo L, Frank G, Pala B, Cianci R, La Placa G, Raffaelli G, Palma R, Peluso D, De Lorenzo A, Gualtieri P, On Behalf Of Clinical Nutrition And Nutrigenomics Project Group. | Microorganisms | 10.3390/microorganisms13071694 | 2025 | |
| Association between gut microbiota composition and physical functioning in patients with knee osteoarthritis: a machine learning study. | de Sire A, Mancuso E, Marotta N, Massimino M, Zito R, Averta C, Bartalotta I, Palummo A, Cerantonio A, Citrigno L, Soverini M, Castagnetti A, Mannino GC, Ammendolia A, Andreozzi F. | Sci Rep | 10.1038/s41598-025-24500-y | 2025 | |
| Probiotic Engraftment of Akkermansia muciniphila in an In Vitro Synthetic Microbial Community. | Berkhout MD, de Ram C, Boeren S, Plugge CM, Belzer C. | Microb Ecol | 10.1007/s00248-025-02605-1 | 2025 | |
| Functional Muffins Exert Bifidogenic Effects along with Highly Product-Specific Effects on the Human Gut Microbiota Ex Vivo. | Deyaert S, Poppe J, Dai Vu L, Baudot A, Bubeck S, Bayne T, Krishnan K, Giusto M, Moltz S, Van den Abbeele P. | Metabolites | 10.3390/metabo14090497 | 2024 | |
| Multi-cohort analysis unveils novel microbial targets for the treatment of hyperuricemia and gout. | Qie J, Cao M, Xu M, Zhang Y, Luo L, Sun C, Ke D, Yuan S, Jia W, Qiu T, Li T, Du X, Xiao C, Hong Z, Zhang B. | mSystems | 10.1128/msystems.01091-25 | 2025 | |
| The Probiotic Strain Clostridium butyricum TO-A Produces Butyrate by Utilizing Lactate and Acetate. | Honda S, Eguchi H, Okino Y, Wang DS. | Int J Mol Sci | 10.3390/ijms26072951 | 2025 | |
| Changes in the intestinal microbiota of broiler chicken induced by dietary supplementation of the diatomite-bentonite mixture. | Wesierska E, Micek P, Adamski MG, Gondek K, Lis M, Trela M, Wojtysiak D, Kowal J, Wyrobisz-Papiewska A, Kunstman G, Mosiolek S, Smoron K. | BMC Vet Res | 10.1186/s12917-024-04439-4 | 2025 | |
| Gut microbiota associated with equol production in school-age children. | Wada K, Suda W, Ueno T, Masuoka H, Yamakawa M, Nakashima Y, Sugino M, Mori T, Uchiyama S, Sumoto Y, Kiguchi Y, Hattori M, Nagata C. | Eur J Nutr | 10.1007/s00394-025-03625-w | 2025 | |
| Fostering next-generation probiotics in human gut by targeted dietary modulation: An emerging perspective | Kumari M, Singh P, Nataraj BH, Kokkiligadda A, Naithani H, Azmal Ali S, Behare PV, Nagpal R. | Food Res Int | 2021 | | |
| Gut microbiota and diabetic neuropathy/peripheral artery disease: A two-sample Mendelian randomization study investigating risk factors for diabetic foot ulcers. | Tang G, Wang Y, Wu J, Zhu R, Guo H, Zhang Y, Chen Z. | Medicine (Baltimore) | 10.1097/md.0000000000043637 | 2025 | |
| L-Citrulline Improves Recovery of Enterocytes While Not Affecting Gut Microbiota in an In Vitro Model of Chemotherapy-Induced Gastrointestinal Mucositis. | van der Laan W, Gallardo Molina PA, Koonen DPY, Harmsen HJM, Tissing WJE. | Biomedicines | 10.3390/biomedicines13092244 | 2025 | |
| Long-term alterations in gut microbiota following mild COVID-19 recovery: bacterial and fungal community shifts. | Li D, Zhang DY, Chen SJ, Lv YT, Huang SM, Chen C, Zeng F, Chen RX, Zhang XD, Xiong JX, Chen FD, Jiang YH, Chen Z, Mo CY, Chen JJ, Zhu XL, Zhang LJ, Bai FH. | Front Cell Infect Microbiol | 10.3389/fcimb.2025.1565887 | 2025 | |
| Impact of manipulation of glycerol/diol dehydratase activity on intestinal microbiota ecology and metabolism. | Ramirez Garcia A, Zhang J, Greppi A, Constancias F, Wortmann E, Wandres M, Hurley K, Pascual-Garcia A, Ruscheweyh HJ, Sturla SJ, Lacroix C, Schwab C. | Environ Microbiol | 10.1111/1462-2920.15431 | 2021 | |
| Steatotic Liver Disease in Younger Adults is Associated With Altered Gut Microbiology. | Tashkent Y, Choo JM, Richard A, Wang Z, Calzadilla-Bertot L, Vasil E, Miller S, Taylor SL, Ivey KL, Woodman R, Adler B, Ayonrinde OT, Olynyk JK, Beilin LJ, Mori TA, Wigg AJ, Muller KR, Adams LA, Rogers GB. | Liver Int | 10.1111/liv.70032 | 2025 | |
| Fostering next-generation probiotics in human gut by targeted dietary modulation: An emerging perspective. | Kumari M, Singh P, Nataraj BH, Kokkiligadda A, Naithani H, Azmal Ali S, Behare PV, Nagpal R. | Food Res Int | 10.1016/j.foodres.2021.110716 | 2021 | |
| Metatranscriptomic analysis indicates prebiotic effect of isomalto/malto-polysaccharides on human colonic microbiota in-vitro. | Borewicz K, Hornung B, Gu F, van der Zaal PH, Schols HA, Schaap PJ, Smidt H. | Sci Rep | 10.1038/s41598-024-69685-w | 2024 | |
| A Long-Chain Dextran Produced by Weissella cibaria Boosts the Diversity of Health-Related Gut Microbes Ex Vivo. | Tintore M, Cune J, Vu LD, Poppe J, Van den Abbeele P, Baudot A, de Lecea C. | Biology (Basel) | 10.3390/biology13010051 | 2024 | |
| Rational Design of Live Biotherapeutic Products for the Prevention of Clostridioides difficile Infection. | Ke S, Villafuerte Galvez JA, Sun Z, Cao Y, Pollock NR, Chen X, Kelly CP, Liu YY. | J Infect Dis | 10.1093/infdis/jiae470 | 2025 | |
| A Microphysiological System with an Anaerobic Air-Liquid Interface and Functional Mucus Layer for Coculture of Intestinal Bacteria and Primary Human Colonic Epithelium. | Kim R, Allbritton NL. | Adv Mater Interfaces | 10.1002/admi.202400093 | 2024 | |
| Emerging probiotics: future therapeutics for human gut health. | Duncan SH, Sabater C. | FEMS Microbiol Ecol | 10.1093/femsec/fiaf077 | 2025 | |
| Nisin-like biosynthetic gene clusters are widely distributed across microbiomes. | Hourigan D, Field D, Murray E, Sugrue I, O'Connor PM, Hill C, Ross RP. | mBio | 10.1128/mbio.01545-25 | 2025 | |
| Similar bacterial signatures in the gut microbiota of type 1 and type 2 diabetes patients and its association with G protein-coupled receptor 41 and 43 gene expression. | Demirci M, Taner Z, Keskin FE, Ozyazar M, Kiraz N, Kocazeybek BS, Tokman HB. | J Diabetes Metab Disord | 10.1007/s40200-022-01068-2 | 2022 | |
| The Bifidogenic Effect of 2'Fucosyllactose Is Driven by Age-Specific Bifidobacterium Species, Demonstrating Age as an Important Factor for Gut Microbiome Targeted Precision Medicine. | Firrman J, Deyaert S, Mahalak KK, Liu L, Baudot A, Joossens M, Poppe J, Cameron SJS, Van den Abbeele P. | Nutrients | 10.3390/nu17010151 | 2024 | |
| Associations of gut microbiota with disease development, disease activity, and therapeutic effects in patients with systemic lupus erythematosus. | Nishio J, Sato H, Watanabe E, Masuoka H, Aoki K, Kawazoe M, Wakiya R, Yamada S, Muraoka S, Masuoka S, Hayashi T, Mizutani S, Yamada Z, Koshiba K, Irita I, Kanaji M, Furukawa K, Yajima N, Dobashi H, Hirose W, Ishii Y, Suda W, Nanki T. | Sci Rep | 10.1038/s41598-024-83835-0 | 2024 | |
| 2'-Fucosyllactose helps butyrate producers outgrow competitors in infant gut microbiota simulations. | Versluis DM, Schoemaker R, Looijesteijn E, Geurts JMW, Merks RMH. | iScience | 10.1016/j.isci.2024.109085 | 2024 | |
| Related differences in fecal bacteria of Chinese northern pregnant women of different ages: associations with maternal clinical indicators and neonatal outcomes. | Hu F, Liu G, Sun X, Su Y, Huang M. | Front Microbiol | 10.3389/fmicb.2025.1642516 | 2025 | |
| HMOs Impact the Gut Microbiome of Children and Adults Starting from Low Predicted Daily Doses. | Bajic D, Wiens F, Wintergerst E, Deyaert S, Baudot A, Abbeele PVD. | Metabolites | 10.3390/metabo14040239 | 2024 | |
| Changes in the gut microbiome of older adults according to hypertension control. | Valdez-Palomares F, Texis T, Sanchez-Garcia S, Martinez-Ezquerro JD, la Torre PG, Rodriguez-Dorantes M, Genis-Mendoza A, Fabela S, Palacios-Gonzalez B, Gonzalez-Covarrubias V. | Front Microbiol | 10.3389/fmicb.2025.1605271 | 2025 | |
| HMOs Exert Marked Bifidogenic Effects on Children's Gut Microbiota Ex Vivo, Due to Age-Related Bifidobacterium Species Composition. | Bajic D, Wiens F, Wintergerst E, Deyaert S, Baudot A, Van den Abbeele P. | Nutrients | 10.3390/nu15071701 | 2023 | |
| Effect of a Novel Food Rich in Miraculin on the Intestinal Microbiome of Malnourished Patients with Cancer and Dysgeusia. | Plaza-Diaz J, Brandimonte-Hernandez M, Lopez-Plaza B, Ruiz-Ojeda FJ, Alvarez-Mercado AI, Arcos-Castellanos L, Feliu-Batlle J, Hummel T, Palma-Milla S, Gil A. | Nutrients | 10.3390/nu17020246 | 2025 | |
| Bridging preclinical and clinical gut microbiota research using the ex vivo SIFR® technology. | Van den Abbeele P, Deyaert S, Thabuis C, Perreau C, Bajic D, Wintergerst E, Joossens M, Firrman J, Walsh D, Baudot A. | Front Microbiol | 10.3389/fmicb.2023.1131662 | 2023 | |
| Plasma TMAO Concentrations and Gut Microbiota Composition in Subjects with and Without Metabolic Syndrome: Results from Pilot Study. | Hefni ME, Witthoft CM, Hellstrom P, Johansson I, Esberg A. | Metabolites | 10.3390/metabo15060364 | 2025 | |
| Abnormal blood microbiota profiles are associated with inflammation and immune restoration in HIV/AIDS individuals. | Guo X, Wang Z, Qu M, Guo Y, Yu M, Hong W, Zhang C, Fan X, Song J, Xu R, Zhang J, Huang H, Linghu E, Wang F-S, Sun L, Jiao Y-M. | mSystems | 10.1128/msystems.00467-23 | 2023 | |
| Effect of Postbiotic Bifidobacterium longum CECT 7347 on Gastrointestinal Symptoms, Serum Biochemistry, and Intestinal Microbiota in Healthy Adults: A Randomised, Parallel, Double-Blind, Placebo-Controlled Pilot Study. | Naghibi M, Pont-Beltran A, Lamelas A, Llobregat L, Martinez-Blanch JF, Rojas A, Alvarez B, Lopez Plaza B, Arcos Castellanos L, Chenoll E, Vijayakumar V, Day R. | Nutrients | 10.3390/nu16223952 | 2024 | |
| Disease-associated microbiome signature species in the gut. | Li J, Li J, O'Toole PW. | PNAS Nexus | 10.1093/pnasnexus/pgae352 | 2024 | |
| The Gut Microbiome Obesity Index: A New Analytical Tool in the Metagenomics Workflow for the Evaluation of Gut Dysbiosis in Obese Humans. | Kulecka M, Jaworski P, Zeber-Lubecka N, Balabas A, Piatkowska M, Czarnowski P, Fraczek B, Tarnowski W, Mikula M, Ostrowski J. | Nutrients | 10.3390/nu17142320 | 2025 | |
| Carrot RG-I Reduces Interindividual Differences between 24 Adults through Consistent Effects on Gut Microbiota Composition and Function Ex Vivo. | Van den Abbeele P, Deyaert S, Albers R, Baudot A, Mercenier A. | Nutrients | 10.3390/nu15092090 | 2023 | |
| Walnut kernel pellicle polyphenols: subcritical water extraction, digestive characteristics, and their effect on gut microbiota and metabolites. | Yuan X, Feng Q, Wang Q, Wang T, Qiao Z, Pan H, Zhong Y, Zhuang Y. | Food Chem X | 10.1016/j.fochx.2025.103020 | 2025 | |
| The Association of Short-Chain Fatty Acids with the Occurrence of Gastrointestinal Symptoms in Infants. | Szczuko M, Duliban G, Drozd A, Sochaczewska D, Pokorska-Niewiada K, Zietek M. | Int J Mol Sci | 10.3390/ijms252312487 | 2024 | |
| Geographic patterns of antibiotic resistance in the human gut microbiome: insights from metagenome-assembled genomes across four Chinese provinces. | Zhou S, Liu H, Bai X, Li D, Wang T, Zhong H, Gao W, Sun J. | Front Microbiol | 10.3389/fmicb.2025.1652757 | 2025 | |
| Effects of removing in-feed antibiotics and zinc oxide on the taxonomy and functionality of the microbiota in post weaning pigs. | Ortiz Sanjuan JM, Arguello H, Cabrera-Rubio R, Crispie F, Cotter PD, Garrido JJ, Ekhlas D, Burgess CM, Manzanilla EG. | Anim Microbiome | 10.1186/s42523-024-00306-7 | 2024 | |
| Multi-kingdom microbial signatures in excess body weight colorectal cancer based on global metagenomic analysis. | Zhu X, Xu P, Zhu R, Gao W, Yin W, Lan P, Zhu L, Jiao N. | Commun Biol | 10.1038/s42003-023-05714-0 | 2024 | |
| Yeast mannan rich fraction positively influences microbiome uniformity, productivity associated taxa, and lay performance. | Leigh RJ, Corrigan A, Murphy RA, Taylor-Pickard J, Moran CA, Walsh F. | Anim Microbiome | 10.1186/s42523-024-00295-7 | 2024 | |
| Genome-Based Reclassification of Strain KIST612, Previously Classified as Eubacterium limosum, into a New Strain of Eubacterium callanderi. | Kim JY, Kang B, Oh S, Gil Y, Choi IG, Chang IS. | J Microbiol Biotechnol | 10.4014/jmb.2304.04011 | 2023 | |
| Metagenomic and metabolomic analyses reveal the role of gut microbiome-associated metabolites in diarrhea calves. | Shi Z, Wang Y, Yan X, Ma X, Duan A, Hassan F-u, Wang W, Deng T. | mSystems | 10.1128/msystems.00582-23 | 2023 | |
| Meta-analysis of shotgun sequencing of gut microbiota in obese children with MASLD or MASH. | Zoggeler T, Kavallar AM, Pollio AR, Aldrian D, Decristoforo C, Scholl-Burgi S, Muller T, Vogel GF. | Gut Microbes | 10.1080/19490976.2025.2508951 | 2025 | |
| Intestinal Barrier Impairment Induced by Gut Microbiome and Its Metabolites in School-Age Children with Zinc Deficiency. | Chai X, Chen X, Yan T, Zhao Q, Hu B, Jiang Z, Guo W, Zhang Y. | Nutrients | 10.3390/nu16091289 | 2024 | |
| Maternal Psychological Well-Being as a Protector in Infantile Colic. | Garnacho-Garnacho VE, Rodriguez-Lopez ES, Oliva-Pascual-Vaca A, Goenaga-Echave L, Otero-Campos A. | Nutrients | 10.3390/nu16142342 | 2024 | |
| Microbial and Metabolic Gut Profiling across Seven Malignancies Identifies Fecal Faecalibacillus intestinalis and Formic Acid as Commonly Altered in Cancer Patients. | Kulecka M, Czarnowski P, Balabas A, Turkot M, Kruczkowska-Tarantowicz K, Zeber-Lubecka N, Dabrowska M, Paszkiewicz-Kozik E, Walewski J, Lugowska I, Kosela-Paterczyk H, Rutkowski P, Kluska A, Piatkowska M, Jagiello-Gruszfeld A, Tenderenda M, Gawinski C, Wyrwicz L, Borucka M, Krzakowski M, Zajac L, Kaminski M, Mikula M, Ostrowski J. | Int J Mol Sci | 10.3390/ijms25158026 | 2024 | |
| Gut microbiome derived short chain fatty acids: Promising strategies in necrotising enterocolitis. | Cifuentes MP, Chapman JA, Stewart CJ. | Curr Res Microb Sci | 10.1016/j.crmicr.2024.100219 | 2024 | |
| Profiling and comprehensive analysis of microbiome and ARGs of nurses and nursing workers in China: a cross-sectional study. | Liu Y, Wang F, Zhou Z, Liu B, Wu Z, Pan X. | Sci Rep | 10.1038/s41598-024-82659-2 | 2024 | |
| Trait-based study predicts glycerol/diol dehydratases as a key function of the gut microbiota of hindgut-fermenting carnivores. | Li Q, Ruscheweyh HJ, Ostergaard LH, Libertella M, Simonsen KS, Sunagawa S, Scoma A, Schwab C. | Microbiome | 10.1186/s40168-024-01863-4 | 2024 | |
| Novel Acylated Naringin Enhances Propionate Release and Stimulates the Growth of Flavanone-Metabolizing Bacteria in an In Vitro Batch Fermentation Model. | Ruiz-Alvarez BE, Padilla-de la Rosa JD, Gonzalez Avila M, Sandoval G, Desjardins Y. | Life (Basel) | 10.3390/life15060967 | 2025 | |
| Novel Lactobacillaceae strains and consortia to produce propionate-containing fermentates as biopreservatives. | Buljubasic E, Bambace MF, Christensen MHL, Ng KS, Huertas-Diaz L, Sundekilde U, Marietou A, Schwab C. | Microb Biotechnol | 10.1111/1751-7915.14392 | 2024 | |
| The gut microbiome is associated with susceptibility to febrile malaria in Malian children. | Van Den Ham KM, Bower LK, Li S, Lorenzi H, Doumbo S, Doumtabe D, Kayentao K, Ongoiba A, Traore B, Crompton PD, Schmidt NW. | Nat Commun | 10.1038/s41467-024-52953-8 | 2024 | |
| Assessing the potential for non-digestible carbohydrates toward mitigating adverse effects of antibiotics on microbiota composition and activity in an in vitro colon model of the weaning infant. | Endika MF, Barnett DJM, Olmos EM, Ter Braak CJF, Arts ICW, Penders J, Nauta A, Leemhuis H, Venema K, Smidt H. | FEMS Microbiol Ecol | 10.1093/femsec/fiaf028 | 2025 | |
| The impact of antibiotic exposure on antibiotic resistance gene dynamics in the gut microbiota of inflammatory bowel disease patients. | Zhang Y, Xue G, Wang F, Zhang J, Xu L, Yu C. | Front Microbiol | 10.3389/fmicb.2024.1382332 | 2024 | |
| Gut microbiome composition: link between sports performance and protein absorption? | Fritz P, Fritz R, Boday P, Boday A, Bato E, Kesseru P, Olah C. | J Int Soc Sports Nutr | 10.1080/15502783.2023.2297992 | 2024 | |
| Next generation probiotics for human health: An emerging perspective. | Jan T, Negi R, Sharma B, Kumar S, Singh S, Rai AK, Shreaz S, Rustagi S, Chaudhary N, Kaur T, Kour D, Sheikh MA, Kumar K, Yadav AN, Ahmed N. | Heliyon | 10.1016/j.heliyon.2024.e35980 | 2024 | |
| Research status and development trends of probiotics in clinical applications. | Li Y, Yao Y, Zhang Z, Gan Y. | Front Nutr | 10.3389/fnut.2025.1650883 | 2025 | |
| Dietary polyunsaturated fatty acids effect on cecal microbiome profile of maturing broiler chicken. | Jadhav VV, Fasina YO, Harrison SH. | Poult Sci | 10.1016/j.psj.2025.105167 | 2025 | |
| Integrated fecal macrogenomic and metabolomic analyses reveal celiac disease flora and metabolic profiles associated with Chinese populations. | Xue S, Shi T, Xie J, Liu W, Yao S, Li N, Liu H, Kong W, Gao F. | J Transl Med | 10.1186/s12967-025-06991-5 | 2025 | |
| The Role of Next-Generation Probiotics in Obesity and Obesity-Associated Disorders: Current Knowledge and Future Perspectives. | Vallianou NG, Kounatidis D, Tsilingiris D, Panagopoulos F, Christodoulatos GS, Evangelopoulos A, Karampela I, Dalamaga M. | Int J Mol Sci | 10.3390/ijms24076755 | 2023 | |
| Bacterial and viral assemblages in ulcerative colitis patients following fecal microbiota and fecal filtrate transfer. | Junca H, Steube A, Mrowietz S, Stallhofer J, Vital M, Dos Anjos Borges LG, Pieper DH, Stallmach A. | ISME Commun | 10.1093/ismeco/ycae167 | 2025 | |
| Isolation of potentially novel species expands the genomic and functional diversity of Lachnospiraceae. | Lin X, Hu T, Wu Z, Li L, Wang Y, Wen D, Liu X, Li W, Liang H, Jin X, Xu X, Wang J, Yang H, Kristiansen K, Xiao L, Zou Y. | Imeta | 10.1002/imt2.174 | 2024 | |
| Effects of Lacticaseibacillus paracasei K56 on perceived stress among pregraduate students: a double-blind, randomized, placebo-controlled trial. | Guan Y, Zhu R, Zhao W, Wang L, You L, Zeng Z, Jiang Q, Zhu Z, Gou J, Zhang Q, Guo J, Li K, Zhao L, Li Y, Wang P, Fang B, Hung W, He J, Zhang L, Wang R, He J. | Front Nutr | 10.3389/fnut.2025.1544713 | 2025 | |
| Deciphering unique and shared interactions between the human gut microbiota and oral antidiabetic drugs. | Ren H, Shi Z, Yang F, Wang S, Yuan F, Li T, Li M, Zhu J, Li J, Wu K, Zhang Y, Ning G, Kristiansen K, Wang W, Gu Y, Zhong H. | Imeta | 10.1002/imt2.179 | 2024 | |
| Fecal microbiota transplantation treatment for type 1 diabetes mellitus with malnutrition: a case report. | Xie YC, Jing XB, Chen X, Chen LZ, Zhang SH, Cai XB. | Ther Adv Chronic Dis | 10.1177/20406223221117449 | 2022 | |
| Gut microbes on the risk of advanced adenomas. | Jing Z, Zheng W, Jianwen S, Hong S, Xiaojian Y, Qiang W, Yunfeng Y, Xinyue W, Shuwen H, Feimin Z. | BMC Microbiol | 10.1186/s12866-024-03416-z | 2024 | |
| Causal effects of gut microbiome on hypertension: a Mendelian randomization study. | He G, Cao Y, Wang H, Lv X. | Front Microbiol | 10.3389/fmicb.2023.1276050 | 2023 | |
| Toxic microbiome and progression of chronic kidney disease: insights from a longitudinal CKD-Microbiome Study. | Laiola M, Koppe L, Larabi A, Thirion F, Lange C, Quinquis B, David A, Le Chatelier E, Benoit B, Sequino G, Chanon S, Vieille-Marchiset A, Herpe YE, Alvarez JC, Glorieux G, Krukowski H, Huys GR, Raes J, Fouque D, Massy ZA, Ehrlich SD, Stengel B, Wagner S, CKD-REIN Study collaborators. | Gut | 10.1136/gutjnl-2024-334634 | 2025 | |
| A metagenomic approach to unveil the association between fecal gut microbiota and short-chain fatty acids in diarrhea caused by diarrheagenic Escherichia coli in children. | Gallardo P, Izquierdo M, Viver T, Bustos-Caparros E, Piras D, Vidal RM, Harmsen HMJ, Farfan MJ. | Microb Cell | 10.15698/mic2024.04.820 | 2024 | |
| Microbiome-based therapeutics towards healthier aging and longevity. | Kadyan S, Park G, Singh TP, Patoine C, Singar S, Heise T, Domeier C, Ray C, Kumar M, Behare PV, Chakrabarty P, Efron P, Sheffler J, Nagpal R. | Genome Med | 10.1186/s13073-025-01493-x | 2025 | |
| Insights into the utilisation of 1,2-propanediol and interactions with the cell envelope of Clostridium perfringens. | Huertas-Diaz L, Vestergaard LG, Marietou A, Irla M, Behr J, Somoza MM, Feilberg A, Schwab C. | Gut Pathog | 10.1186/s13099-025-00689-1 | 2025 | |
| Beneficial Bacteria Isolated from Food in Relation to the Next Generation of Probiotics. | Sionek B, Szydlowska A, Zielinska D, Neffe-Skocinska K, Kolozyn-Krajewska D. | Microorganisms | 10.3390/microorganisms11071714 | 2023 | |
| Lacticaseibacillus rhamnosus ATCC 53103 and Limosilactobacillus reuteri ATCC 53608 Synergistically Boost Butyrate Levels upon Tributyrin Administration Ex Vivo. | Van den Abbeele P, Goggans M, Deyaert S, Baudot A, Van de Vliet M, Calatayud Arroyo M, Lelah M. | Int J Mol Sci | 10.3390/ijms24065859 | 2023 | |
| Novel insights into carbohydrate utilisation, antimicrobial resistance, and sporulation potential in Roseburia intestinalis isolates across diverse geographical locations. | Mukhopadhya I, Martin JC, Shaw S, Gutierrez-Torrejon M, Boteva N, McKinley AJ, Gratz SW, Scott KP. | Gut Microbes | 10.1080/19490976.2025.2473516 | 2025 | |
| Gut Microbiota and Clinical Manifestations in Thai Pediatric Patients with Attention-Deficit Hyperactivity Disorder. | Panpetch J, Kiatrungrit K, Tuntipopipat S, Tangphatsornruang S, Mhuantong W, Chongviriyaphan N. | J Pers Med | 10.3390/jpm14070739 | 2024 | |
| Systematic identification of secondary bile acid production genes in global microbiome. | Yang Y, Gao W, Zhu R, Tao L, Chen W, Zhu X, Shen M, Xu T, Zhao T, Zhang X, Zhu L, Jiao N. | mSystems | 10.1128/msystems.00817-24 | 2025 | |
| Bifidobacterium species serve as key gut microbiome regulators after intervention in gestational diabetes mellitus. | Cui Z, Wang S, Niu J, Ma J, Yang H. | BMC Microbiol | 10.1186/s12866-024-03680-z | 2024 | |
| Blood-borne immune cells carry low biomass DNA remnants of microbes in patients with colorectal cancer or inflammatory bowel disease. | Morsy Y, Walberg A, Wawrzyniak P, Hubeli B, Truscello L, Mamie C, Niechcial A, Gueguen E, Manzini R, Gottier C, Lang S, Scharl S, Blumel S, Biedermann L, Rogler G, Turina M, Ramser M, Petrowsky H, Arnold IC, Zeissig S, Zamboni N, Egli A, Niess JH, Hruz P, Knuth A, Fritsch R, Manz MG, Wawrzyniak M, Scharl M. | Gut Microbes | 10.1080/19490976.2025.2530157 | 2025 | |
| Examining the Interaction between Exercise, Gut Microbiota, and Neurodegeneration: Future Research Directions. | Rojas-Valverde D, Bonilla DA, Gomez-Miranda LM, Calleja-Nunez JJ, Arias N, Martinez-Guardado I. | Biomedicines | 10.3390/biomedicines11082267 | 2023 | |
| Role of Akkermansia in Human Diseases: From Causation to Therapeutic Properties. | Pellegrino A, Coppola G, Santopaolo F, Gasbarrini A, Ponziani FR. | Nutrients | 10.3390/nu15081815 | 2023 | |
| Distribution, organization and expression of genes concerned with anaerobic lactate utilization in human intestinal bacteria. | Sheridan PO, Louis P, Tsompanidou E, Shaw S, Harmsen HJ, Duncan SH, Flint HJ, Walker AW. | Microb Genom | 10.1099/mgen.0.000739 | 2022 | |
| Personalized prediction of glycemic responses to food in women with diet-treated gestational diabetes: the role of the gut microbiota. | Popova PV, Isakov AO, Rusanova AN, Sitkin SI, Anopova AD, Vasukova EA, Tkachuk AS, Nemikina IS, Stepanova EA, Eriskovskaya AI, Stepanova EA, Pustozerov EA, Kokina MA, Vasilieva EY, Vasilyeva LB, Zgairy S, Rubin E, Even C, Turjeman S, Pervunina TM, Grineva EN, Koren O, Shlyakhto EV. | NPJ Biofilms Microbiomes | 10.1038/s41522-025-00650-9 | 2025 | |
| Change in the Gut Microbiome and Immunity by Lacticaseibacillus rhamnosus Probio-M9. | Zhang M, Zheng Y, Sun Z, Cao C, Zhao W, Liu Y, Zhang W, Zhang H. | Microbiol Spectr | 10.1128/spectrum.03609-22 | 2023 | |
| Temporal Dynamics of the Intestinal Microbiome Following Short-Term Dietary Restriction. | Anderson EM, Rozowsky JM, Fazzone BJ, Schmidt EA, Stevens BR, O'Malley KA, Scali ST, Berceli SA. | Nutrients | 10.3390/nu14142785 | 2022 | |
| Microbially-produced folate forms support the growth of Roseburia intestinalis but not its competitive fitness in fecal batch fermentations. | Kundra P, Geirnaert A, Pugin B, Pluss S, Kariluoto S, Lacroix C, Greppi A. | BMC Microbiol | 10.1186/s12866-024-03528-6 | 2024 | |
| Microbiome signature suggestive of lactose-intolerance in rhesus macaques (Macaca mulatta) with intermittent chronic diarrhea. | Maaskant A, Voermans B, Levin E, de Goffau MC, Plomp N, Schuren F, Remarque EJ, Smits A, Langermans JAM, Bakker J, Montijn R. | Anim Microbiome | 10.1186/s42523-024-00338-z | 2024 | |
| The impact of regular sauerkraut consumption on the human gut microbiota: a crossover intervention trial. | Schropp N, Bauer A, Stanislas V, Huang KD, Lesker TR, Bielecka AA, Strowig T, Michels KB. | Microbiome | 10.1186/s40168-024-02016-3 | 2025 | |
| Biological effects of combinations of structurally diverse human milk oligosaccharides. | Wichmann A. | Front Pediatr | 10.3389/fped.2024.1439612 | 2024 | |
| 2-Fucosyllactose Metabolism by Bifidobacteria Promotes Lactobacilli Growth in Co-Culture. | Nogacka AM, Cuesta I, Gueimonde M, de Los Reyes-Gavilan CG. | Microorganisms | 10.3390/microorganisms11112659 | 2023 | |
| Role of the gut microbiota in nutrient competition and protection against intestinal pathogen colonization. | Horrocks V, King OG, Yip AYG, Marques IM, McDonald JAK. | Microbiology (Reading) | 10.1099/mic.0.001377 | 2023 | |
| Tungsten is utilized for lactate consumption and SCFA production by a dominant human gut microbe Eubacterium limosum. | Putumbaka S, Schut GJ, Thorgersen MP, Poole FL, Shao N, Rodionov DA, Adams MWW. | Proc Natl Acad Sci U S A | 10.1073/pnas.2411809121 | 2025 | |
| Are Faecal Microbiota Analyses on Species-Level Suitable Clinical Biomarkers? A Pilot Study in Subjects with Morbid Obesity. | Farup PG, Maseng MG. | Microorganisms | 10.3390/microorganisms9030664 | 2021 | |
| Temporal response patterns of human gut microbiota to dietary fiber. | Lin X, Wang C, Liu B, Zhu Y, Zhai R, Zhang C. | Imeta | 10.1002/imt2.70046 | 2025 | |
| Anaerobic Feces Processing for Fecal Microbiota Transplantation Improves Viability of Obligate Anaerobes. | Benard MV, Arretxe I, Wortelboer K, Harmsen HJM, Davids M, de Bruijn CMA, Benninga MA, Hugenholtz F, Herrema H, Ponsioen CY. | Microorganisms | 10.3390/microorganisms11092238 | 2023 | |
| Collinsella aerofaciens as a predictive marker of response to probiotic treatment in non-constipated irritable bowel syndrome. | Gargari G, Mantegazza G, Cremon C, Taverniti V, Valenza A, Barbaro MR, Marasco G, Duncan R, Fiore W, Ferrari R, De Vitis V, Barbara G, Guglielmetti S. | Gut Microbes | 10.1080/19490976.2023.2298246 | 2024 | |
| Microbiota Predict Infections and Acute Graft-Versus-Host Disease After Pediatric Allogeneic Hematopoietic Stem Cell Transplantation. | Margolis EB, Alfaro GM, Sun Y, Dallas RH, Allison KJ, Ferrolino J, Ross HS, Davis AE, Jia Q, Turner P, Mackay V, Morin CE, Triplett BM, Klein EJ, Englund JA, Tang L, Hayden RT. | J Infect Dis | 10.1093/infdis/jiad190 | 2023 | |
| Profiling of the intestinal community of Clostridia: taxonomy and evolutionary analysis. | Candeliere F, Musmeci E, Amaretti A, Sola L, Raimondi S, Rossi M. | Microbiome Res Rep | 10.20517/mrr.2022.19 | 2023 | |
| Gut microbiome metabolites, molecular mimicry, and species-level variation drive long-term efficacy and adverse event outcomes in lung cancer survivors. | Liu X, Lu B, Tang H, Jia X, Zhou Q, Zeng Y, Gao X, Chen M, Xu Y, Wang M, Tan B, Li J. | EBioMedicine | 10.1016/j.ebiom.2024.105427 | 2024 | |
| Using whole-genome sequencing (WGS) to plot colorectal cancer-related gut microbiota in a population with varied geography. | Shuwen H, Yinhang W, Xingming Z, Jing Z, Jinxin L, Wei W, Kefeng D. | Gut Pathog | 10.1186/s13099-022-00524-x | 2022 | |
| A Fecal Metabolite Signature of Impaired Fasting Glucose: Results From Two Independent Population-Based Cohorts. | Nogal A, Tettamanzi F, Dong Q, Louca P, Visconti A, Christiansen C, Breuninger T, Linseisen J, Grallert H, Wawro N, Asnicar F, Wong K, Baleanu AF, Michelotti GA, Segata N, Falchi M, Peters A, Franks PW, Bagnardi V, Spector TD, Bell JT, Gieger C, Valdes AM, Menni C. | Diabetes | 10.2337/db23-0170 | 2023 | |
| Coenzyme A metabolism: a key driver of gut microbiota dynamics and metabolic profiles. | Bottcher J, Sibon OCM, El Aidy S. | FEMS Microbiol Rev | 10.1093/femsre/fuaf051 | 2025 | |
| Insights into the Relationship Between the Gut Microbiome and Immune Checkpoint Inhibitors in Solid Tumors. | Ciernikova S, Sevcikova A, Novisedlakova M, Mego M. | Cancers (Basel) | 10.3390/cancers16244271 | 2024 | |
| Compositional and functional variability of the gut microbiome in children with infantile colic. | Kozhakhmetov S, Meiirmanova Z, Mukhanbetzhanov N, Jarmukhanov Z, Vinogradova E, Mureyev S, Kozhakhmetova S, Morenko M, Shnaider K, Duisbayeva A, Kushugulova A. | Sci Rep | 10.1038/s41598-023-36641-z | 2023 | |
| Gut microbiota wellbeing index predicts overall health in a cohort of 1000 infants. | Hickman B, Salonen A, Ponsero AJ, Jokela R, Kolho KL, de Vos WM, Korpela K. | Nat Commun | 10.1038/s41467-024-52561-6 | 2024 | |
| Distinct gut microbiomes in Thai patients with colorectal polyps. | Intarajak T, Udomchaiprasertkul W, Khoiri AN, Sutheeworapong S, Kusonmano K, Kittichotirat W, Thammarongtham C, Cheevadhanarak S. | World J Gastroenterol | 10.3748/wjg.v30.i27.3336 | 2024 | |
| Breastfeeding and the major fermentation metabolite lactate determine occurrence of Peptostreptococcaceae in infant feces. | Huertas-Diaz L, Kyhnau R, Ingribelli E, Neuzil-Bunesova V, Li Q, Sasaki M, Lauener RP, Roduit C, Frei R, Study Group CC, Sundekilde U, Schwab C. | Gut Microbes | 10.1080/19490976.2023.2241209 | 2023 | |
| In-depth characterization of a selection of gut commensal bacteria reveals their functional capacities to metabolize dietary carbohydrates with prebiotic potential. | Bedu-Ferrari C, Biscarrat P, Pepke F, Vati S, Chaudemanche C, Castelli F, Chollet C, Rue O, Hennequet-Antier C, Langella P, Cherbuy C. | mSystems | 10.1128/msystems.01401-23 | 2024 | |
| Microbial-Based Bioactive Compounds to Alleviate Inflammation in Obesity. | Apalowo OE, Adegoye GA, Obuotor TM. | Curr Issues Mol Biol | 10.3390/cimb46030119 | 2024 | |
| Supplementation with a cranberry extract favors the establishment of butyrogenic guilds in the human fermentation SHIME system. | Cattero V, Roussel C, Lessard-Lord J, Roy D, Desjardins Y. | Microbiome Res Rep | 10.20517/mrr.2024.17 | 2024 | |
| Gut microbiota predicts severity and reveals novel metabolic signatures in acute pancreatitis. | Ammer-Herrmenau C, Antweiler KL, Asendorf T, Beyer G, Buchholz SM, Cameron S, Capurso G, Damm M, Dang L, Frost F, Gomes A, Hamm J, Henker R, Hoffmeister A, Meinhardt C, Nawacki L, Nunes V, Panyko A, Pardo C, Phillip V, Pukitis A, Rasch S, Riekstina D, Rinja E, Ruiz-Rebollo ML, Sirtl S, Weingarten M, Sandru V, Woitalla J, Ellenrieder V, Neesse A. | Gut | 10.1136/gutjnl-2023-330987 | 2024 | |
| Strain-Level Dynamics Reveal Regulatory Roles in Atopic Eczema by Gut Bacterial Phages. | Chu Y, Meng Q, Yu J, Zhang J, Chen J, Kang Y. | Microbiol Spectr | 10.1128/spectrum.04551-22 | 2023 | |
| Microbial Signatures in COVID-19: Distinguishing Mild and Severe Disease via Gut Microbiota. | Galeeva JS, Fedorov DE, Starikova EV, Manolov AI, Pavlenko AV, Selezneva OV, Klimina KM, Veselovsky VA, Morozov MD, Yanushevich OO, Krikheli NI, Levchenko OV, Andreev DN, Sokolov FS, Fomenko AK, Devkota MK, Andreev NG, Zaborovskiy AV, Bely PA, Tsaregorodtsev SV, Evdokimov VV, Maev IV, Govorun VM, Ilina EN. | Biomedicines | 10.3390/biomedicines12050996 | 2024 | |
| Phylogeny and disease associations of a widespread and ancient intestinal bacteriophage lineage. | de Jonge PA, van den Born BH, Zwinderman AH, Nieuwdorp M, Dutilh BE, Herrema H. | Nat Commun | 10.1038/s41467-024-50777-0 | 2024 | |
| Metagenomic Sequencing Analysis Identifies Cross-Cohort Gut Microbial Signatures Associated With Age-Related Macular Degeneration. | Xue W, Peng P, Wen X, Meng H, Qin Y, Deng T, Guo S, Chen T, Li X, Liang J, Zhang F, Xie Z, Jin M, Liang Q, Wei L. | Invest Ophthalmol Vis Sci | 10.1167/iovs.64.5.11 | 2023 | |
| Improvements to postprandial glucose control in subjects with type 2 diabetes: a multicenter, double blind, randomized placebo-controlled trial of a novel probiotic formulation. | Perraudeau F, McMurdie P, Bullard J, Cheng A, Cutcliffe C, Deo A, Eid J, Gines J, Iyer M, Justice N, Loo WT, Nemchek M, Schicklberger M, Souza M, Stoneburner B, Tyagi S, Kolterman O. | BMJ Open Diabetes Res Care | 10.1136/bmjdrc-2020-001319 | 2020 | |
| Teasing out missing reactions in genome-scale metabolic networks through hypergraph learning. | Chen C, Liao C, Liu YY. | Nat Commun | 10.1038/s41467-023-38110-7 | 2023 | |
| Gut microbiota response to in vitro transit time variation is mediated by microbial growth rates, nutrient use efficiency and adaptation to in vivo transit time. | Minnebo Y, Delbaere K, Goethals V, Raes J, Van de Wiele T, De Paepe K. | Microbiome | 10.1186/s40168-023-01691-y | 2023 | |
| Multi-omics reveals specific host metabolism-microbiome associations in intracerebral hemorrhage. | Chen L, Wang S, Zhang Y, Li Y, Zhang X, Ma J, Zou X, Yao T, Li S, Chen J, Zhou H, Wu L, Zhou Y, Zhang L. | Front Cell Infect Microbiol | 10.3389/fcimb.2022.999627 | 2022 | |
| Maternal microbiota and gestational diabetes: impact on infant health. | Singh P, Elhaj DAI, Ibrahim I, Abdullahi H, Al Khodor S. | J Transl Med | 10.1186/s12967-023-04230-3 | 2023 | |
| BIOME-Preserve: A novel storage and transport medium for preserving anaerobic microbiota samples for culture recovery. | Hyde ER, Lozano H, Cox S. | PLoS One | 10.1371/journal.pone.0261820 | 2022 | |
| Characterization of Two Parabacteroides distasonis Candidate Strains as New Live Biotherapeutics against Obesity. | Cuffaro B, Boutillier D, Desramaut J, Jablaoui A, Werkmeister E, Trottein F, Waligora-Dupriet AJ, Rhimi M, Maguin E, Grangette C. | Cells | 10.3390/cells12091260 | 2023 | |
| Comparative analysis of Parkinson's and inflammatory bowel disease gut microbiomes reveals shared butyrate-producing bacteria depletion. | Krueger ME, Boles JS, Simon ZD, Alvarez SD, McFarland NR, Okun MS, Zimmermann EM, Forsmark CE, Tansey MG. | NPJ Parkinsons Dis | 10.1038/s41531-025-00894-4 | 2025 | |
| Glycerol and reuterin-producing Limosilactobacillus reuteri enhance butyrate production and inhibit Enterobacteriaceae in broiler chicken cecal microbiota PolyFermS model. | Asare PT, Greppi A, Geirnaert A, Pennacchia A, Babst A, Lacroix C. | BMC Microbiol | 10.1186/s12866-023-03091-6 | 2023 | |
| The Potential Prebiotic Berberine Combined With Methimazole Improved the Therapeutic Effect of Graves' Disease Patients Through Regulating the Intestinal Microbiome. | Han Z, Cen C, Ou Q, Pan Y, Zhang J, Huo D, Chen K. | Front Immunol | 10.3389/fimmu.2021.826067 | 2021 | |
| Advanced Organotypic In Vitro Model Systems for Host-Microbial Coculture. | Kim R. | Biochip J | 10.1007/s13206-023-00103-5 | 2023 | |
| Metaproteomics reveals parallel utilization of colonic mucin glycans and dietary fibers by the human gut microbiota. | Raba G, Luis AS, Schneider H, Morell I, Jin C, Adamberg S, Hansson GC, Adamberg K, Arike L. | iScience | 10.1016/j.isci.2024.110093 | 2024 | |
| Investigating Antibody Reactivity to the Intestinal Microbiome in Severe Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A Feasibility Study. | Seton KA, Defernez M, Telatin A, Tiwari SK, Savva GM, Hayhoe A, Noble A, de Carvalho-KoK ALS, James SA, Bansal A, Wileman T, Carding SR. | Int J Mol Sci | 10.3390/ijms242015316 | 2023 | |
| Alterations in the intestinal microbiome and metabolic profile of patients with cirrhosis supplemented with lactulose, Clostridium butyricum, and Bifidobacterium longum infantis: a randomized placebo-controlled trial. | Lu H, Zhu X, Wu L, Lou X, Pan X, Liu B, Zhang H, Zhu L, Li L, Wu Z. | Front Microbiol | 10.3389/fmicb.2023.1169811 | 2023 | |
| In vitro Fermentation Reveals Changes in Butyrate Production Dependent on Resistant Starch Source and Microbiome Composition. | Teichmann J, Cockburn DW. | Front Microbiol | 10.3389/fmicb.2021.640253 | 2021 | |
| Impact of Novel Foods on the Human Gut Microbiome: Current Status. | Martinez A, Velazquez L, Diaz R, Huaiquipan R, Perez I, Munoz A, Valdes M, Sepulveda N, Paz E, Quinones J. | Microorganisms | 10.3390/microorganisms12091750 | 2024 | |
| Stepwise establishment of functional microbial groups in the infant gut between 6 months and 2 years: A prospective cohort study. | Pham VT, Greppi A, Chassard C, Braegger C, Lacroix C. | Front Nutr | 10.3389/fnut.2022.948131 | 2022 | |
| The abundance of Ruminococcus bromii is associated with faecal butyrate levels and atopic dermatitis in infancy. | Sasaki M, Schwab C, Ramirez Garcia A, Li Q, Ferstl R, Bersuch E, Akdis CA, Lauener R, CK-CARE study group, Frei R, Roduit C. | Allergy | 10.1111/all.15440 | 2022 | |
| Characterization of fructooligosaccharide metabolism and fructooligosaccharide-degrading enzymes in human commensal butyrate producers. | Tanno H, Fujii T, Hirano K, Maeno S, Tonozuka T, Sakamoto M, Ohkuma M, Tochio T, Endo A. | Gut Microbes | 10.1080/19490976.2020.1869503 | 2021 | |
| Profiling gut microbiota and bile acid metabolism in critically ill children. | Kean IRL, Wagner J, Wijeyesekera A, De Goffau M, Thurston S, Clark JA, White DK, Ridout J, Agrawal S, Kayani R, O'Donnell R, Ramnarayan P, Peters MJ, Klein N, Holmes E, Parkhill J, Baker S, Pathan N, Pathan N. | Sci Rep | 10.1038/s41598-022-13640-0 | 2022 | |
| Probiotic Bifidobacterium longum supplied with methimazole improved the thyroid function of Graves' disease patients through the gut-thyroid axis. | Huo D, Cen C, Chang H, Ou Q, Jiang S, Pan Y, Chen K, Zhang J. | Commun Biol | 10.1038/s42003-021-02587-z | 2021 | |
| Pathogenic and Commensal Gut Bacteria Harboring Glycerol/Diol Dehydratase Metabolize Glycerol and Produce DNA-Reactive Acrolein. | Ramirez Garcia A, Hurley K, Marastoni G, Diard M, Hofer S, Greppi A, Hardt WD, Lacroix C, Sturla SJ, Schwab C. | Chem Res Toxicol | 10.1021/acs.chemrestox.2c00137 | 2022 | |
| Microbiome and Metabolome Variation as Indicator of Social Stress in Female Prairie Voles. | Nuccio DA, Normann MC, Zhou H, Grippo AJ, Singh P. | Int J Mol Sci | 10.3390/ijms24021677 | 2023 | |
| Microbial Gene Ontology informed deep neural network for microbe functionality discovery in human diseases. | Liu Y, Zhang YZ, Imoto S. | PLoS One | 10.1371/journal.pone.0290307 | 2023 | |
| Genomic reconstruction of short-chain fatty acid production by the human gut microbiota. | Frolova MS, Suvorova IA, Iablokov SN, Petrov SN, Rodionov DA. | Front Mol Biosci | 10.3389/fmolb.2022.949563 | 2022 | |
| The oral-gut axis: Salivary and fecal microbiome dysbiosis in patients with inflammatory bowel disease. | Abdelbary MMH, Hatting M, Bott A, Dahlhausen A, Keller D, Trautwein C, Conrads G. | Front Cell Infect Microbiol | 10.3389/fcimb.2022.1010853 | 2022 | |
| Effects of antibiotic duration on the intestinal microbiota and resistome: The PIRATE RESISTANCE project, a cohort study nested within a randomized trial. | Leo S, Lazarevic V, von Dach E, Kaiser L, Prendki V, Schrenzel J, Huttner BD, Huttner A. | EBioMedicine | 10.1016/j.ebiom.2021.103566 | 2021 | |
| A proof of concept infant-microbiota associated rat model for studying the role of gut microbiota and alleviation potential of Cutibacterium avidum in infant colic. | Rocha Martin VN, Del'Homme C, Chassard C, Schwab C, Braegger C, Bernalier-Donadille A, Lacroix C. | Front Nutr | 10.3389/fnut.2022.902159 | 2022 | |
| The gut microbiota in multiple sclerosis varies with disease activity. | Thirion F, Sellebjerg F, Fan Y, Lyu L, Hansen TH, Pons N, Levenez F, Quinquis B, Stankevic E, Sondergaard HB, Dantoft TM, Poulsen CS, Forslund SK, Vestergaard H, Hansen T, Brix S, Oturai A, Sorensen PS, Ehrlich SD, Pedersen O. | Genome Med | 10.1186/s13073-022-01148-1 | 2023 | |
| Unravelling lactate-acetate and sugar conversion into butyrate by intestinal Anaerobutyricum and Anaerostipes species by comparative proteogenomics. | Shetty SA, Boeren S, Bui TPN, Smidt H, de Vos WM. | Environ Microbiol | 10.1111/1462-2920.15269 | 2020 | |
| Human Milk Oligosaccharides and Lactose Differentially Affect Infant Gut Microbiota and Intestinal Barrier In Vitro. | Natividad JM, Marsaux B, Rodenas CLG, Rytz A, Vandevijver G, Marzorati M, Van den Abbeele P, Calatayud M, Rochat F. | Nutrients | 10.3390/nu14122546 | 2022 | |
| Gut-on-a-Chip for the Analysis of Bacteria-Bacteria Interactions in Gut Microbial Community: What Would Be Needed for Bacterial Co-Culture Study to Explore the Diet-Microbiota Relationship? | Lee KW, Shin JS, Lee CM, Han HY, O Y, Kim HW, Cho TJ. | Nutrients | 10.3390/nu15051131 | 2023 | |
| Bile acid-independent protection against Clostridioides difficile infection. | Aguirre AM, Yalcinkaya N, Wu Q, Swennes A, Tessier ME, Roberts P, Miyajima F, Savidge T, Sorg JA. | PLoS Pathog | 10.1371/journal.ppat.1010015 | 2021 | |
| Identification of New Potential Biotherapeutics from Human Gut Microbiota-Derived Bacteria. | Cuffaro B, Assohoun ALW, Boutillier D, Peucelle V, Desramaut J, Boudebbouze S, Croyal M, Waligora-Dupriet AJ, Rhimi M, Grangette C, Maguin E. | Microorganisms | 10.3390/microorganisms9030565 | 2021 | |
| Update of the list of qualified presumption of safety (QPS) recommended microbiological agents intentionally added to food or feed as notified to EFSA 18: Suitability of taxonomic units notified to EFSA until March 2023. | EFSA Panel on Biological Hazards (BIOHAZ), Koutsoumanis K, Allende A, Alvarez-Ordonez A, Bolton D, Bover-Cid S, Chemaly M, De Cesare A, Hilbert F, Lindqvist R, Nauta M, Nonno R, Peixe L, Ru G, Simmons M, Skandamis P, Suffredini E, Cocconcelli PS, Fernandez Escamez PS, Maradona MP, Querol A, Sijtsma L, Suarez JE, Sundh I, Barizzone F, Correia S, Herman L. | EFSA J | 10.2903/j.efsa.2023.8092 | 2023 | |
| The associations of butyrate-producing bacteria of the gut microbiome with diet quality and muscle health. | Davis JA, Collier F, Mohebbi M, Pasco JA, Shivappa N, Hebert JR, Jacka FN, Loughman A. | Gut Microbiome (Camb) | 10.1017/gmb.2021.2 | 2021 | |
| Gut OncoMicrobiome Signatures (GOMS) as next-generation biomarkers for cancer immunotherapy. | Thomas AM, Fidelle M, Routy B, Kroemer G, Wargo JA, Segata N, Zitvogel L. | Nat Rev Clin Oncol | 10.1038/s41571-023-00785-8 | 2023 | |
| Gut Microbiome Changes in Patients with Active Left-Sided Ulcerative Colitis after Fecal Microbiome Transplantation and Topical 5-aminosalicylic Acid Therapy. | Schierova D, Brezina J, Mrazek J, Fliegerova KO, Kvasnova S, Bajer L, Drastich P. | Cells | 10.3390/cells9102283 | 2020 | |
| Metaproteomics characterizes human gut microbiome function in colorectal cancer. | Long S, Yang Y, Shen C, Wang Y, Deng A, Qin Q, Qiao L. | NPJ Biofilms Microbiomes | 10.1038/s41522-020-0123-4 | 2020 | |
| Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma. | Bjork JR, Bolte LA, Maltez Thomas A, Lee KA, Rossi N, Wind TT, Smit LM, Armanini F, Asnicar F, Blanco-Miguez A, Board R, Calbet-Llopart N, Derosa L, Dhomen N, Brooks K, Harland M, Harries M, Lorigan P, Manghi P, Marais R, Newton-Bishop J, Nezi L, Pinto F, Potrony M, Puig S, Serra-Bellver P, Shaw HM, Tamburini S, Valpione S, Waldron L, Zitvogel L, Zolfo M, de Vries EGE, Nathan P, Fehrmann RSN, Spector TD, Bataille V, Segata N, Hospers GAP, Weersma RK. | Nat Med | 10.1038/s41591-024-02803-3 | 2024 | |
| The Specific Carbohydrate Diet and Diet Modification as Induction Therapy for Pediatric Crohn's Disease: A Randomized Diet Controlled Trial. | Suskind DL, Lee D, Kim YM, Wahbeh G, Singh N, Braly K, Nuding M, Nicora CD, Purvine SO, Lipton MS, Jansson JK, Nelson WC. | Nutrients | 10.3390/nu12123749 | 2020 | |
| Butyrate to combat obesity and obesity-associated metabolic disorders: Current status and future implications for therapeutic use. | van Deuren T, Blaak EE, Canfora EE. | Obes Rev | 10.1111/obr.13498 | 2022 | |
| gapseq: informed prediction of bacterial metabolic pathways and reconstruction of accurate metabolic models. | Zimmermann J, Kaleta C, Waschina S. | Genome Biol | 10.1186/s13059-021-02295-1 | 2021 | |
| A comprehensive evaluation of binning methods to recover human gut microbial species from a non-redundant reference gene catalog. | Borderes M, Gasc C, Prestat E, Galvao Ferrarini M, Vinga S, Boucinha L, Sagot MF. | NAR Genom Bioinform | 10.1093/nargab/lqab009 | 2021 | |
| Gut microbiota modulation with long-chain corn bran arabinoxylan in adults with overweight and obesity is linked to an individualized temporal increase in fecal propionate. | Nguyen NK, Deehan EC, Zhang Z, Jin M, Baskota N, Perez-Munoz ME, Cole J, Tuncil YE, Seethaler B, Wang T, Laville M, Delzenne NM, Bischoff SC, Hamaker BR, Martinez I, Knights D, Bakal JA, Prado CM, Walter J. | Microbiome | 10.1186/s40168-020-00887-w | 2020 | |
| Linking human milk oligosaccharide metabolism and early life gut microbiota: bifidobacteria and beyond. | Lordan C, Roche AK, Delsing D, Nauta A, Groeneveld A, MacSharry J, Cotter PD, van Sinderen D. | Microbiol Mol Biol Rev | 10.1128/mmbr.00094-23 | 2024 | |
| Therapeutic Strategies to Modulate Gut Microbial Health: Approaches for Chronic Metabolic Disorder Management. | Rondanelli M, Borromeo S, Cavioni A, Gasparri C, Gattone I, Genovese E, Lazzarotti A, Minonne L, Moroni A, Patelli Z, Razza C, Sivieri C, Valentini EM, Barrile GC. | Metabolites | 10.3390/metabo15020127 | 2025 | |
| Reclassification of Eubacterium hallii as Anaerobutyricum hallii gen. nov., comb. nov., and description of Anaerobutyricum soehngenii sp. nov., a butyrate and propionate-producing bacterium from infant faeces. | Shetty SA, Zuffa S, Bui TPN, Aalvink S, Smidt H, De Vos WM | Int J Syst Evol Microbiol | 10.1099/ijsem.0.003041 | 2018 | |
How to citeIf you want to cite this particular strain cite the following doi:
https://doi.org/10.13145/bacdive5428.20251217.10
When using BacDive for research please cite the following paper
BacDive in 2025: the core database for prokaryotic strain data
License